Next Generation Sequencing

Next generation sequencing (NGS), massively parallel or deep sequencing are related terms that describe a DNA sequencing technology which has revolutionized genomic research. The global next Generation Sequencing market is poised to grow at a CAGR of more than 20% to reach around $5.0 billion by 2020. The NGS market assessment was made based on products, technologies, end users, applications and geography.

The power of high–throughput DNA sequencing technologies is being harnessed by researchers to address an increasingly diverse range of biological problems. NGS technologies have wide applications in many research areas including De novo sequencing of bacterial & viral genomes, searching for genetic variants by resequencing whole genome or targeted genome regions, understanding the genetic mechanisms underlying human gene expression variation and characterizing the transcriptome of cells.

  • Exome sequencing
  • Hybrid sequencing approach
  • Sequencing Technologies
  • NGS Data Analysis
  • Role of NGS in Cancer Drug Development
  • Clinical Applications of NGS
  • Advances of NGS in Therapeutics

Related Conference of Next Generation Sequencing

October 10-11, 2016

World Congress on Molecular Biology

Dubai, UAE
October 10-12, 2016

2nd World Bio Summit & Expo

Dubai, UAE
November 07- 08, 2016

World Congress on Human Genetics

Barcelona, Spain
November 7-9, 2016

12th Euro
Biotechnology Congress

Alicante, Spain
November 28-30, 2016

13th Biotechnology Congress

San Francisco, USA
March 20-22, 2017

8th World Congress and Expo on Cell & Stem Cell Research

Orlando, Florida, USA
April 10-12, 2017

14th Asia-PacificBiotech Congress

Indonesia
July 03-05, 2017

7th International Conference on Plant Genomics

Bangkok, Thailand
August 07-09,2017

2nd Annual Conference on Bioscience

China, Beijing
December 04-06, 2017

2nd World Biotechnology Congress

Sao Paulo, Brazil

Next Generation Sequencing Conference Speakers

Recommended Sessions

Related Journals

Are you interested in